Skip to main content
NVDA+0.53%AAPL-0.77%GOOGL-1.39%MSFT-0.91%AMZN-1.63%TSM-1.11%SPCX-2.60%META-0.11%AVGO-1.39%TSLA+0.59%SKHY-1.27%BRK-B+0.07%LLY+0.42%MU+0.14%JPM-1.60%WMT-0.56%AMD+1.99%V-0.14%XOM+2.24%JNJ-0.74%ASMLa-1.02%0700.HK+1.90%MA-0.26%INTC+1.24%ABBV+0.54%1398.HK-2.09%CSCO+0.30%CVX+1.84%BAC-0.77%ORCL-0.69%COST-1.48%KO-1.30%DELL+2.29%CAT-0.28%0005.HK-3.21%HSBA.L-2.33%PG+0.37%UNH-1.66%LRCX-2.59%AP2d-2.07%AMAT-1.46%1816.HK-0.46%3988.HK-2.13%NFLX-2.91%GE-2.46%MS-2.27%0857.HK+0.60%HD-1.69%PM-0.15%0939.HK-2.83%USDJPY+0.98%NZDUSD-0.94%CHFJPY+0.76%USDTHB+0.70%CADJPY+0.68%NZDCHF-0.64%NZDCAD-0.64%AUDUSD-0.60%GBPJPY+0.56%GBPNZD+0.55%EURUSD-0.51%EURJPY+0.45%EURNZD+0.44%GBPTRY+0.41%AUDJPY+0.40%GBPUSD-0.39%PLNJPY+0.36%AUDNZD+0.35%NOKJPY+0.34%GBPHKD+0.32%USDCAD+0.31%USDCHF+0.31%SGDJPY+0.29%GBPMXN-0.28%AUDCHF-0.28%AUDCAD-0.28%USDSEK+0.27%USDTRY+0.25%NZDMXN-0.24%EURCAD-0.23%GBPZAR-0.20%EURSEK+0.19%USDSGD+0.19%EURCHF-0.19%GBPAUD+0.18%USDILS+0.16%NZDSGD-0.16%USDNOK+0.13%USDPLN+0.12%GBPCHF-0.11%USDMXN+0.11%EURSGD+0.11%EURCZK+0.10%EURAUD+0.10%GBPCAD-0.09%EURGBP-0.09%AUDDKK-0.08%USDDKK+0.08%CHFSEK+0.08%EURHKD-0.07%EURZAR-0.06%CHFNOK-0.06%USDCNH+0.06%EURNOK+0.05%NZDJPY+0.04%EURPLN+0.04%EURCNH-0.04%USDCOP-0.04%GBPSGD-0.03%AUDSGD+0.03%AUDNOK-0.03%USDHKD+0.02%CADCHF-0.01%USDZAR+0.01%CHFSGD-0.01%EURDKK0.00%USOIL+3.10%COCOA-2.91%COFFEE-2.02%UKOIL+1.66%W1+1.61%S1+1.26%SUGAR-0.99%XNGUSD+0.90%C1+0.80%HG1+0.70%COTTON-0.38%GAGUSD+0.32%BTCUSD-2.25%ETHUSD-3.73%USDTUSD-0.04%XRPUSD-2.24%SOLUSD-3.23%TRXUSDT-0.44%ZECUSDT-3.79%DOGEUSD-2.33%XMRUSDT-0.23%LINKUSD-2.14%XLMUSD-0.03%BCHUSDT-0.85%UNIUSD-2.21%LTCUSD-2.61%HBARUSDT+0.29%TONUSD+26.79%SUIUSD-2.43%TAOUSDT-3.07%AAVEUSD-2.89%DOTUSDT-1.71%ICPUSDT-7.80%ONDOUSDT-3.43%WLDUSDT-1.82%ARBUSDT+14.16%ATOMUSDT-1.72%JUPUSDT-4.30%INJUSDT-10.53%STXUSDT-3.11%FETUSDT-4.41%PYTHUSDT-3.05%TIAUSDT-5.30%SEIUSDT-2.47%IMXUSDT-1.00%OPUSDT-1.70%GRTUSDT-3.39%POLUSDT+0.96%WIFUSDT-4.27%IOTAUSDT-5.82%AXSUSDT-2.99%FARTCOINUSDT-1.12%EOSUSDT-4.57%DYDXUSDT-5.96%ORDIUSDT-2.08%GALAUSDT-1.47%NOTUSDT-1.28%RONINUSDT-14.59%NVDA+0.53%AAPL-0.77%GOOGL-1.39%MSFT-0.91%AMZN-1.63%TSM-1.11%SPCX-2.60%META-0.11%AVGO-1.39%TSLA+0.59%SKHY-1.27%BRK-B+0.07%LLY+0.42%MU+0.14%JPM-1.60%WMT-0.56%AMD+1.99%V-0.14%XOM+2.24%JNJ-0.74%ASMLa-1.02%0700.HK+1.90%MA-0.26%INTC+1.24%ABBV+0.54%1398.HK-2.09%CSCO+0.30%CVX+1.84%BAC-0.77%ORCL-0.69%COST-1.48%KO-1.30%DELL+2.29%CAT-0.28%0005.HK-3.21%HSBA.L-2.33%PG+0.37%UNH-1.66%LRCX-2.59%AP2d-2.07%AMAT-1.46%1816.HK-0.46%3988.HK-2.13%NFLX-2.91%GE-2.46%MS-2.27%0857.HK+0.60%HD-1.69%PM-0.15%0939.HK-2.83%USDJPY+0.98%NZDUSD-0.94%CHFJPY+0.76%USDTHB+0.70%CADJPY+0.68%NZDCHF-0.64%NZDCAD-0.64%AUDUSD-0.60%GBPJPY+0.56%GBPNZD+0.55%EURUSD-0.51%EURJPY+0.45%EURNZD+0.44%GBPTRY+0.41%AUDJPY+0.40%GBPUSD-0.39%PLNJPY+0.36%AUDNZD+0.35%NOKJPY+0.34%GBPHKD+0.32%USDCAD+0.31%USDCHF+0.31%SGDJPY+0.29%GBPMXN-0.28%AUDCHF-0.28%AUDCAD-0.28%USDSEK+0.27%USDTRY+0.25%NZDMXN-0.24%EURCAD-0.23%GBPZAR-0.20%EURSEK+0.19%USDSGD+0.19%EURCHF-0.19%GBPAUD+0.18%USDILS+0.16%NZDSGD-0.16%USDNOK+0.13%USDPLN+0.12%GBPCHF-0.11%USDMXN+0.11%EURSGD+0.11%EURCZK+0.10%EURAUD+0.10%GBPCAD-0.09%EURGBP-0.09%AUDDKK-0.08%USDDKK+0.08%CHFSEK+0.08%EURHKD-0.07%EURZAR-0.06%CHFNOK-0.06%USDCNH+0.06%EURNOK+0.05%NZDJPY+0.04%EURPLN+0.04%EURCNH-0.04%USDCOP-0.04%GBPSGD-0.03%AUDSGD+0.03%AUDNOK-0.03%USDHKD+0.02%CADCHF-0.01%USDZAR+0.01%CHFSGD-0.01%EURDKK0.00%USOIL+3.10%COCOA-2.91%COFFEE-2.02%UKOIL+1.66%W1+1.61%S1+1.26%SUGAR-0.99%XNGUSD+0.90%C1+0.80%HG1+0.70%COTTON-0.38%GAGUSD+0.32%BTCUSD-2.25%ETHUSD-3.73%USDTUSD-0.04%XRPUSD-2.24%SOLUSD-3.23%TRXUSDT-0.44%ZECUSDT-3.79%DOGEUSD-2.33%XMRUSDT-0.23%LINKUSD-2.14%XLMUSD-0.03%BCHUSDT-0.85%UNIUSD-2.21%LTCUSD-2.61%HBARUSDT+0.29%TONUSD+26.79%SUIUSD-2.43%TAOUSDT-3.07%AAVEUSD-2.89%DOTUSDT-1.71%ICPUSDT-7.80%ONDOUSDT-3.43%WLDUSDT-1.82%ARBUSDT+14.16%ATOMUSDT-1.72%JUPUSDT-4.30%INJUSDT-10.53%STXUSDT-3.11%FETUSDT-4.41%PYTHUSDT-3.05%TIAUSDT-5.30%SEIUSDT-2.47%IMXUSDT-1.00%OPUSDT-1.70%GRTUSDT-3.39%POLUSDT+0.96%WIFUSDT-4.27%IOTAUSDT-5.82%AXSUSDT-2.99%FARTCOINUSDT-1.12%EOSUSDT-4.57%DYDXUSDT-5.96%ORDIUSDT-2.08%GALAUSDT-1.47%NOTUSDT-1.28%RONINUSDT-14.59%
CP

Catalyst Pharmaceuticals, Inc. (CPRX)

NASDAQ • Healthcare

$31.49
+$0 (+0.0%)
Market open

Last close at July 21, 2026 at 20:00 UTC

Open$31.49
Previous Close$31.49
Day Range$31.49 - $31.49
Avg. Volume (3M)0
Market Cap$3.8B
P/E Ratio17.5
52 Week Range
$19.05$32.56

Metrics Over Time

Where the Money Goes

Q1 2026
Revenueeverything earned$149.3M100%
Gross Profitminus cost of goods$125.2M84%
Operating Incomeminus R&D and overhead$73.2M49%
Net Incomeminus taxes and the rest$63.7M43%

In plain terms: out of every $100 in revenue, Catalyst Pharmaceuticals, Inc. keeps $43 as net profit.

Fundamentals & Financials

Revenue (TTM)
$596.9M
Net Income (TTM)
$221.3M
EPS (TTM)
$1.8
ROA (TTM)
19.29%
Current Ratio
7.1

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-15.7%Q4 2025$0.43
0.0%Q1 2026$0.42
-18.8%Q2 2026$0.52

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q2 2026
Miss -18.8%

Catalyst Pharmaceuticals’ adjusted EPS of $0.52 trailed the $0.64 estimate by 18.8% and rose 10.6% from $0.47 a year ago, while revenue of $149.4 million was in line with the $149.5 million consensus, -0.1%, in the fiscal first quarter of 2026 reported on May 11. Revenue increased 5.6% to about $149.4 million from $141.4 million a year earlier, with gross margin near 83.8% and operating margin around 49.0% as the company kept profitability high. Net income climbed 12.3% to about $63.7 million from $56.7 million a year ago, operating cash flow came in at about $59.6 million, and Catalyst repurchased roughly $14.6 million of stock. For the next period, consensus calls for adjusted EPS of $0.48 on revenue of $155.8 million.

View full earnings history

About Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is a commercial-stage biotechnology company that discovers, develops, and markets therapies for rare, severe, and chronic neuromuscular and neurological disorders in the United States. The company generated $589.0 million in revenue in FY2025 from a business centered on approved LEMS treatments and follow-on development.

Name
Catalyst Pharmaceuticals, Inc.
CEO
Richard John Daly
Website
www.catalystpharma.com
Industry
Healthcare
Year Founded
2002
Employees
182

Today's Snapshot

AI-generated

CPRX started the session flat at 31.49, in line with a flat sector. The session opened with CPRX within 3.3% of its 52-week high of 32.56.

vs S&P 500 Today

Moderate Outperformance

+0.36%

Updated: September 15, 2026 at 15:09 UTC

Technical Indicators

5 Buy1 Neutral2 Sell
CPRX is showing a strong technical bias supported by a very high ADX (around 69), above‑average OBV and price sitting at $31.49 with short and medium moving averages aligned under the current level while the 200‑day averages remain well lower, indicating broad bullish placement. Momentum readings are mixed—RSI is near overbought while MACD is only modestly positive—yet volatility is unusually low, with ATR near $0.05, which has kept moves contained. Classic and Fibonacci pivots align with the current price, offering little near‑term resistance. Technical takeaway: Strong buy driven by a powerful trend and confirming volume.
All signals
  • EMA (5 indicators)$25.69 - $31.48
    Buy
  • RSI (14)70.17
    Sell
  • Stochastic %K (14, 3, 3)85.71
    Sell
  • MACD Level (12, 26)0.12
    Neutral

Peers & Related Assets

EXELExelixis, Inc.
$56.21+0.2%
MDGLMadrigal Pharmaceuticals, Inc.
$540.06+1.0%
AXSMAxsome Therapeutics, Inc.
$216.58-1.9%
AMLXAmylyx Pharmaceuticals, Inc.
$33.64+6.4%
VKTXViking Therapeutics, Inc.
$31.53-1.4%
VSTMVerastem, Inc.
$7.51+2.6%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.